Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Shares Issued: 2024-2025

Historic Shares Issued for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $760,000.

  • Upstream Bio's Shares Issued rose 3900.00% to $760,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $273.5 million, marking a year-over-year change of. This contributed to the annual value of $272.7 million for FY2024, which is 231021.19% up from last year.
  • Per Upstream Bio's latest filing, its Shares Issued stood at $760,000 for Q3 2025, which was down 99.72% from $272.6 million recorded in Q4 2024.
  • In the past 5 years, Upstream Bio's Shares Issued ranged from a high of $272.6 million in Q4 2024 and a low of $12,000 during Q1 2024.
  • For the 2-year period, Upstream Bio's Shares Issued averaged around $54.7 million, with its median value being $100,000 (2024).
  • Data for Upstream Bio's Shares Issued shows a peak YoY skyrocketed of 3,900.00% (in 2025) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Shares Issued (Quarterly) stood at $272.6 million in 2024, then soared by 3,900.00% to $760,000 in 2025.
  • Its Shares Issued stands at $760,000 for Q3 2025, versus $272.6 million for Q4 2024 and $19,000 for Q3 2024.